Tharimmune to Present at the Microcap Conference 2025

Arizona Tribune - Tharimmune to Present at the Microcap Conference 2025

Tharimmune to Present at the Microcap Conference 2025

BRIDGEWATER, NJ / ACCESS Newswire / January 27, 2025 / Tharimmune, Inc. (Nasdaq:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company committed to pioneering therapies in immunology and inflammation, today announced its participation in The Microcap Conference 2025 being held January 28-30, 2025, in Atlantic City, N.J.

Text size:

Management will deliver a corporate presentation and engage in one-on-one meetings with institutional and individual investors to discuss the company's recent developments, growth strategy, and investment opportunities.

Event: The Microcap Conference 2025
Location: Studio 4, Borgata Hotel Casino & Spa
Date: Thursday January 30, 2025
Time: 10:00 AM Eastern Time

Investors interested in meeting with management can register for the conference here.

About Tharimmune

Tharimmune, Inc. is a clinical-stage biotechnology company developing a diverse portfolio of therapeutic candidates in immunology, inflammation and oncology. Its lead clinical asset, TH104, aims to suppress chronic pruritus associated with primary biliary cholangitis (PBC), a rare autoimmune liver disease with no known cure. The expanded pipeline includes TH023, an oral TNF-alpha inhibitor, offering a new approach to treating autoimmune diseases. Tharimmune is also advancing early-stage multi-specific biologics targeting unique epitopes against multiple solid tumors. The company has a license agreement with OmniAb, Inc. to access their antibody discovery technology for targeting specified disease markers. For more information, please visit: www.tharimmune.com.

Contacts

Tharimmune, Inc.
[email protected]

Alliance Advisors IR
Tirth T. Patel
[email protected]
212-201-6614

Contact Information

Tirth Patel
Alliance Advisors IR
[email protected]
1-212-201-6614

SOURCE: Tharimmune Inc.

View the original press release on ACCESS Newswire

W.Morales--AT

RBGPF	0.7%	62.64	$
RYCEF	-2.63%	7.22	$
CMSC	-0.42%	23.8	$
SCS	-0.78%	11.59	$
RELX	0.57%	49.4	$
NGG	-0.69%	61.08	$
GSK	-1.14%	35.1	$
RIO	-3.46%	59.9	$
BTI	-1.12%	39.17	$
CMSD	-0.83%	24.17	$
BP	-0.93%	31.16	$
BCC	-0.42%	127.64	$
JRI	0.95%	12.69	$
BCE	-0.75%	23.88	$
VOD	-0.71%	8.51	$
AZN	-0.7%	69.59	$

Arizona Tribune - Tharimmune to Present at the Microcap Conference 2025

Tharimmune to Present at the Microcap Conference 2025

Featured

UK's first AI classroom without teachers sparks debate

DeepSeek, Chinese AI startup roiling US tech giants

DeepSeek breakthrough raises AI energy questions

Games music composer with ambition to define an artform